![]() This isn’t the first warning to surface for the Johnson & Johnson vaccine. ![]() Most people with GBS fully recover, though some patients will experience lingering effects.Īs most hospitalizations and deaths linked to COVID are occurring among unvaccinated people, the Centers for Disease Control and Prevention (CDC) states that the benefits of the Johnson & Johnson vaccine outweigh the risks from the vaccine. If GBS progresses, muscle weakness can evolve into paralysis. It most commonly begins with tingling and weakness in the feet and legs, spreading to the upper body. GBS is a rare condition in which the body’s immune system attacks nerve cells. ![]() įor more about what you need to know about the COVID vaccines as a person with diabetes, click here.The federal government database has identified 100 suspected cases of Guillain-Barre syndrome (GBS) among the 12.8 million who received the Johnson & Johnson vaccine. The CDC and FDA encourages all Johnson and Johnson vaccine recipients to monitor the aforementioned symptoms and report any adverse effects to the Vaccine Adverse Event Reporting System at. While the pause is not permanent, the CDC and FDA’s pause is part of the regulatory process to keep recipients of the COVID-19 vaccines informed and safe. The fact sheets will inform benefit risk determinations for healthcare providers administering the vaccines. Once more information is known, Mark says that the two organizations will update the fact sheet for both healthcare providers and vaccine recipients. Tomorrow, April 14, the CDC will meet with the Advisory Committee on Immunization Practices (ACIP) to further investigate these cases and inform next steps. She says if people begin to experience symptoms such as severe headache, abdominal pain, leg pain, or shortness of breath, to seek out medical treatment. “For people who recently got the vaccine within the last couple weeks, they should be aware to look for any symptoms,” Schuchat says in the FDA and CDC joint media call. “With cerebral venous sinus thrombosis, heparin may be dangerous and alternative treatments need to be given preferably under the guidance of physicians experienced in the treatment of blood clots,” Marks says in the FDA and CDC joint media call.Īnne Schuchat, MD, CDC’s principal deputy director says that for people who have gotten the vaccine over a month ago, the risk is very low. Peter Marks, MD, PhD, director for the FDA Center for Biologics Evaluation and Research notes that treatment for the CVST blood clot is different compared to treatments for other types of blood clots, which usually involves an anticoagulant drug called heparin. So far, what is known about the reported cases is that all occurred six to 13 days post Johnson and Johnson vaccination among women between the ages of 18 and 48. “We’re recommending this pause while we work together to fully understand these events and also, so we can get information out to healthcare providers and vaccine recipients,” Woodcock says. “COVID-19 vaccine safety is a top priority for the federal government and we take all reports of adverse events following vaccination seriously.”Īs of April 12, more than 6.8 million doses of the Johnson and Johnson vaccine have been administered and the CDC and FDA are currently investigating the matter further to provide guidance not only to health professionals, but for current recipients of the Johnson and Johnson COVID-19 vaccine. ![]() “Right now, I like to stress these events appear to be extremely rare,” Woodcock states. Janet Woodcock, MD, acting FDA commissioner stresses in a CDC and FDA joint media call that adverse reactions to vaccines are extremely rare and the advisory reflects the CDC and FDA’s abundance of caution they have around vaccine safety. Today, the CDC and FDA released a recommendation to pause the distribution of the Johnson and Johnson vaccine in the United States due to reported cases of a rare blood clot called cerebral venous sinus thrombosis (CVST) linked to low platelet counts following vaccination. UPDATE: As of Friday, April 23, the CDC and FDA approved the J&J vaccine for use again, after an 11 day pause. Looking for more information on all COVID vaccines and diabetes? Click here. Visit to learn more about what you can do as a person with diabetes to keep yourself and others safe from COVID-19 until we’re all safe. Editor’s Note: We have a simple goal: tap into the power of the global diabetes community to save lives. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |